Napactadine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C14H16N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 571S87U90N, chemically known as 2-naphthaleneethanimidamide, n,n-dimethyl-, monohydrochloride but generally known as napactadine, which bears US NIH Compound Identifier 42152. European Medicines Agency schedules Napactadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09152MIG. The term NAPACTADINE is an International Non-Proprietary Name. NAPACTADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule napactadine under HS 29252900 and SITC 51482. As of Q4 2014, NAPACTADINE remains the US FDA Preferred Term for this commodity. Napactadine bears US NLM identifiers UMLS ID C0625911 and NCI Concept Code C87744. SMILES: Cl.[NH2](/C(=N\C)Cc1cc2c(cc1)cccc2)C.